Abstract 16 Table 1
Donor Left Ventricular Hypertrophy >1.2 cm (n=86)
EndpointsHypertension (n=27)No Hypertension (n=59)P-Value
Incidence of Primary Graft Dysfunction (%)3.7%5.1%1.000
1 Year Survival81.5%98.3%0.003
1 Year Freedom from Any-Treated Rejection85.2%81.4%0.647
1 Year Freedom from Acute Cellular Rejection96.3%98.3%0.532
1 Year Freedom from Antibody-Mediated Rejection92.6%88.1%0.531
1 Year Freedom from CAV92.6%94.9%0.552
LVH >1.2 cm at 6 Months Post-Transplantation, %40.7%40.7%1.000
LVH >1.2 cm at 12 Months Post-Transplantation,%38.9%43.2%0.785